These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13896889)

  • 1. Does urinary calcium excretion reflect growth or regression of disseminated breast cancer?
    GARDNER B; GORDAN GS
    J Clin Endocrinol Metab; 1962 Jun; 22():627-30. PubMed ID: 13896889
    [No Abstract]   [Full Text] [Related]  

  • 2. Urine calcium excretion studies as a means of selection of hormone dependent tumors.
    JESSIMAN AG
    Surg Forum; 1956; 6():411-4. PubMed ID: 13391507
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium excretion (CaE) in metastatic breast cancer.
    Campbell FC; Blamey RW; Woolfson AM; Elston CW; Hosking DJ
    Br J Surg; 1983 Apr; 70(4):202-4. PubMed ID: 6831170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Connection of blood calcium with urinary calcium excretion in skeletal metastases of carcinoma].
    GERBRANDY J; HELLENDOORN HB; SAN TJIANG B
    Ned Tijdschr Geneeskd; 1956 Sep; 100(39):2784-9. PubMed ID: 13378581
    [No Abstract]   [Full Text] [Related]  

  • 5. [Excretion of calcium in the urine in patients with osteolytic bone metastases].
    GERBRANDY J; EBELING LC
    Ned Tijdschr Geneeskd; 1955 Nov; 99(47):3565-7. PubMed ID: 13288643
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium and magnesium excretion in urine in breast cancer as evaluation of testosterone therapy].
    STRIEBEL A; VON PLANTA P; VIOLLIER G
    Schweiz Med Wochenschr; 1955 Feb; 85(8):167-70. PubMed ID: 14358628
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of serum phosphohexose isomerase activity and urinary calcium excretion in a patient with metastatic mammary carcinoma.
    MYERS WP; BODANSKY O
    Am J Med; 1957 Nov; 23(5):804-9. PubMed ID: 13478599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary excretion of 17-hydroxycorticosteroids in patients with malignant neoplasms of the breast before and after stimulation with ACTH].
    IANNIRUBERTO A; MARONE A
    Arch Ostet Ginecol; 1959; 64():652-62. PubMed ID: 14405815
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary excretion of deoxypyridinoline in patients with breast cancer.
    Nguyen-Pamart M; Bonneterre J; Hecquet B
    Anticancer Res; 1995; 15(4):1601-3. PubMed ID: 7654055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
    Stromberg K; Duffy M; Fritsch C; Hudgins WR; Sharp ES; Murphy LD; Lippman ME; Bates SE
    Cancer Detect Prev; 1991; 15(4):277-83. PubMed ID: 1794134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endocrine ablative surgery on the urinary excretion of 17-ketosteroids in advanced cancer of the breast.
    HOBKIRK R
    J Clin Endocrinol Metab; 1958 Jun; 18(6):636-42. PubMed ID: 13539175
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of endocrine therapy for advanced breast cancer.
    PEARSON OH; WEST CD; HOLLANDER VP; TREVES NE
    J Am Med Assoc; 1954 Jan; 154(3):234-9. PubMed ID: 13108703
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of breast structure and oestrogen and pregnanediol excretion in mammary cancer patiens.
    JULL JW; DOSSETT PJ; SHUCKSMITH HS; BONSER GM
    Acta Unio Int Contra Cancrum; 1959; 15():1108-13. PubMed ID: 14408140
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary excretion of isoflavonoids and the risk of breast cancer.
    Zheng W; Dai Q; Custer LJ; Shu XO; Wen WQ; Jin F; Franke AA
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):35-40. PubMed ID: 9950237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary estrogens in carcinoma of the breast].
    CARNIELLI P
    Friuli Med; 1959; 14():675-94. PubMed ID: 13807829
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphaturia in hypercalcemic breast cancer patients.
    Schussler GC; Verso M; Nemoto T
    J Clin Endocrinol Metab; 1972 Oct; 35(4):497-504. PubMed ID: 5052972
    [No Abstract]   [Full Text] [Related]  

  • 17. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy.
    Secreto G; Zumoff B
    Cancer Res; 1983 Jul; 43(7):3408-11. PubMed ID: 6850646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary hydroxyproline excretion in patients with breast cancer.
    Cuschieri A; Felgate R
    Br J Surg; 1971 Nov; 58(11):862. PubMed ID: 5124876
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary hydroxyproline excretion and survival in cancer of the breast.
    Cuschieri A
    Clin Oncol; 1975 Jun; 1(2):127-30. PubMed ID: 1183101
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogen excretion in breast cancer patients before and after ovarian irradiation and oophorectomy.
    DICZFALUSY E; NOTTER G; EDSMYR F; WESTMAN A
    J Clin Endocrinol Metab; 1959 Oct; 19():1230-44. PubMed ID: 13816627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.